← Leaderboards
Kathy L Rowlen
University Of Colorado At Boulder
$12,210,052
Attributed
$12,210,052
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$12,210,052 · 7
By mechanism
R44$5,313,220 · 2
U01$4,764,535 · 2
R43$1,200,000 · 2
R41$932,297 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado At Boulder
Same institution · by research overlap
- Kristi S. Anseth$19,055,455
- Christopher N Bowman$8,220,035
- Rebecca O Bendick$45,044,965
- Hadley D Sikes$486,013
- Christopher N Bowman$6,869,651
Others in their field
Top investigators on “Vaccine Production”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$302,758,006
- Dennis R. Burton · Scripps Research Institute$288,205,431
- David Heimbrook · Leidos Biomedical Research, Inc.$143,325,407
- Mark S Klempner · Tufts Medical Center$129,182,794
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,304,758
Research focus
Vaccine ProductionInnovationTechnologyHourInfluenzaDesignHandProteinsCostReagentBaseMethodologyReaderCenters For Disease Control And Prevention (U.S.)ResponseSignal TransductionSuccessPrototypeDiagnosticDetectionSamplingColoradoSiteNational Institute Of Allergy And Infectious Disease
Grant awards (23)
Innovative Optical System for Hemagglutination Assays$994,754
R44 · FY2017 · AI · contact PI
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION$395,688
R44 · FY2017 · AI · contact PI
Innovative Optical System for Hemagglutination Assays$996,634
R44 · FY2016 · AI · contact PI
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION$935,011
R44 · FY2016 · AI · contact PI
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION$1,030,988
R44 · FY2015 · AI · contact PI
INNOVATIVE OPTICAL SYSTEM FOR HEMAGGLUTINATION ASSAYS$300,000
R43 · FY2015 · AI · contact PI
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION$960,145
R44 · FY2014 · AI · contact PI
INNOVATIVE OPTICAL SYSTEM FOR HEMAGGLUTINATION ASSAYS$300,000
R43 · FY2014 · AI · contact PI
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION$300,000
R43 · FY2013 · AI · contact PI
TITER ON CHIP: ALTERNATIVE TO SRID FOR INFLUENZA VACCINE POTENCY DETERMINATION$300,000
R43 · FY2012 · AI · contact PI
Advanced Microarray Technology for Pathogen Surveillance$457,039
U01 · FY2010 · AI · contact PI
Advanced Microarray Technology for Pathogen Surveillance$767,247
U01 · FY2009 · AI · contact PI
Advanced Microarray Technology for Pathogen Surveillance$87,899
U01 · FY2009 · AI · contact PI
Advanced Microarray Technology for Pathogen Surveillance$486,988
U01 · FY2008 · AI · contact PI
Advanced Microarray Technology for Pathogen Surveillance$504,273
U01 · FY2007 · AI · contact PI
Development of Diagnostic Microarray for Influenza A$472,624
U01 · FY2007 · AI · contact PI
Development of Diagnostic Microarray for Influenza A$473,227
U01 · FY2006 · AI · contact PI
Advanced Microarray Technology for Pathogen Surveillance$435,803
U01 · FY2006 · AI · contact PI
Development of Diagnostic Microarray for Influenza A$483,067
U01 · FY2005 · AI
Advanced Detection Technologies for Biochips$473,193
R41 · FY2005 · AI
Advanced Detection Technologies for Biochips$459,104
R41 · FY2004 · AI
Development of Diagnostic Microarray for Influenza A$365,742
U01 · FY2004 · AI
Development of Diagnostic Microarray for Influenza A$230,626
U01 · FY2003 · AI